Regulus Therapeutics
RGLS
#7200
Rank
ยฃ0.43 B
Marketcap
ยฃ6.24
Share price
0.00%
Change (1 day)
436.78%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): -ยฃ0.57

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.56. In 2024 the company made an earnings per share (EPS) of -ยฃ0.66.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.57-14.73%
2024-ยฃ0.66
2022-ยฃ1.42-43.12%
2021-ยฃ2.50-40.55%
2020-ยฃ4.20-50%
2019-ยฃ8.41-80.36%
2018-ยฃ42.79-57.8%
2017-ยฃ101.40-28.66%
2016-ยฃ142.1342.2%
2015-ยฃ99.95-14.84%
2014-ยฃ117.37156%
2013-ยฃ45.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ1.51-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.80-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.45-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.44-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.20-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ0.29-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ15.14-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA